Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter.
The key pathological features of Alzheimer's disease include synaptic dysfunction, profound changes in the cholinergic system, and deposition of beta-amyloid peptides generated by proteolytic processing of the amyloid-beta precursor protein (APP). However, the pathways linking APP with synaptic activity and cholinergic neuronal function are poorly understood. We report here that APP is essential in regulating the presynaptic expression and activity of the high-affinity choline transporter (CHT), a molecule that mediates the rate-limiting step of cholinergic synaptic transmission in both the neuromuscular junction and central cholinergic neurons. Loss of APP leads to aberrant localization of CHT at the neuromuscular synapses and reduced CHT activity at cholinergic projections. At the cellular level, we show that APP and CHT can be found in Rab5-positive endosomal compartments and that APP affects CHT endocytosis. Furthermore, we demonstrate that APP interacts with CHT through the C-terminal domain, providing support for a specific and direct regulation of CHT by APP through protein-protein interactions. These results identify a physiological activity of APP in cholinergic neurons, and our data indicate that deregulation of APP function may contribute to cholinergic impairment and AD pathogenesis.
Wang
Baiping
B
Huffington Center on Aging and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Yang
Li
L
Wang
Zilai
Z
Zheng
Hui
H
D000544:Alzheimer Disease / Q000503:physiopathology; D016564:Amyloid beta-Protein Precursor / Q000502:physiology*; D000818:Animals; D001369:Axons / Q000502:physiology; D006706:Homeostasis; D006801:Humans; D008322:Mammals; D026901:Membrane Transport Proteins / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D009046:Motor Neurons / Q000502:physiology; D009469:Neuromuscular Junction / Q000502:physiology; D017729:Presynaptic Terminals / Q000502:physiology; D013569:Synapses / Q000502:physiology
D016564:Amyloid beta-Protein Precursor; D026901:Membrane Transport Proteins; C065637:choline transporter
J Neurochem. 2003 Oct;87(1):136-46
12969261
J Neurosci. 2004 Jun 16;24(24):5459-66
15201317
J Neurosci. 2003 Jan 15;23(2):539-49
12533614
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8760-5
12070348
J Comp Neurol. 1983 Jun 10;217(1):103-21
6875049
Science. 2002 Jul 19;297(5580):353-6
12130773
Neuron. 2001 Aug 16;31(3):381-94
11516396
J Neurosci. 2003 Jul 2;23(13):5407-15
12843239
J Neurosci. 2003 Oct 29;23(30):9697-709
14585997
J Neurosci. 2006 Jun 7;26(23):6200-12
16763028
Annu Rev Neurosci. 1999;22:389-442
10202544
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8762-7
15173594
Cell. 1995 May 19;81(4):525-31
7758106
Neuron. 2004 Jan 8;41(1):27-33
14715132
J Neurosci. 1993 Jul;13(7):3136-42
8331390
J Neurosci. 2000 Nov 1;20(21):7951-63
11050115
J Clin Invest. 1994 Aug;94(2):696-702
8040324
J Neurosci. 2005 Feb 2;25(5):1219-25
15689559
Science. 2005 Feb 25;307(5713):1282-8
15731448
Nat Genet. 2006 Jan;38(1):24-6
16369530
J Cell Biol. 1995 Apr;129(2):431-42
7721945
Brain Res. 1992 Oct 2;592(1-2):353-7
1280522
Brain Res. 1991 Nov 1;563(1-2):184-94
1786532
Neurobiol Aging. 1997 Nov-Dec;18(6):661-9
9461064
J Neurochem. 2005 Jul;94(1):86-96
15953352
J Cell Sci. 2001 Dec;114(Pt 24):4499-508
11792815
Nat Rev Neurosci. 2005 Jan;6(1):48-56
15611726
Science. 1986 Dec 5;234(4781):1237-40
3775382
Neuron. 2003 Jun 5;38(5):678-80
12797952
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16532-7
17062754
Mol Neurodegener. 2006 Jul 03;1:5
16930452
Neuroscience. 2004;125(4):1009-17
15120860
Prog Neurobiol. 1999 Feb;57(2):165-224
9987805
Neuron. 2003 Jan 9;37(1):67-73
12526773
Nature. 1998 May 28;393(6683):382-6
9620803
J Neurosci. 1998 Nov 15;18(22):9269-81
9801366
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1561-5
1689489
J Clin Invest. 2006 Mar;116(3):825-32
16498501